Main > ONCOLOGY (**) > Leukemia>Myeloid>Acute>Newly Diag+> > TREAT.: > USA. AG. Venetoclax Tablets

---

USA. AG. Venetoclax Tablets's subsections
(*) USA Approval Date: 2020. 10.19
+low-dose cytarabine (LDAC) CT
Companies
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2021. 02.23.
TradeMark
TradeMark Web-Site

USA. AG. Venetoclax Tablets's products
This section has no products